SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-075413
Filing Date
2023-09-08
Accepted
2023-09-08 16:30:09
Documents
12
Period of Report
2023-09-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea184934-8k_bluewater.htm   iXBRL 8-K 24111
  Complete submission text file 0001213900-23-075413.txt   198174

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bwv-20230902.xsd EX-101.SCH 3012
3 XBRL LABEL FILE bwv-20230902_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bwv-20230902_pre.xml EX-101.PRE 22358
6 EXTRACTED XBRL INSTANCE DOCUMENT ea184934-8k_bluewater_htm.xml XML 3420
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Blue Water Biotech, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 231245669
SIC: 2834 Pharmaceutical Preparations